Market News / Story
IRLAB to present at Redeye Theme: Neurology
MFN by Modular Finance ·
MFN by Modular Finance reports: Gothenburg, October 9, 2026 — IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that CEO Kristina Torfgård will present IRLAB at Redeye Theme: Neurology on October 15 in Stockholm. Both Swedish and international investors will participate in the meeting, providing the company with excellent opportunities to expand its network and establish new contacts. The event…